Cliff Asness’s KALA BIO KALA Stock Holding History

Cliff Asness’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8	Closed	-$138K	–	2231
2020 Q4	$138K	Sell	8 -6	-43%	-$113K	﹤0.01%	2128
2020 Q3	$253K	Buy	14 +6	+75%	+$138K	﹤0.01%	1981
2020 Q2	$219K	Buy	+8	New	+$227K	﹤0.01%	1972

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cliff Asness's KALA Position: Q1 2021 in Review

Cliff Asness sold out of KALA BIO (KALA) in Q1 2021, closing a stake of 8 shares — an estimated $138K sold.

Cliff Asness first reported a position in KALA in Q2 2020 and held it in 3 quarters. The position peaked at $253K in Q3 2020. 106 funds tracked by Wall St. Rank hold KALA as of Q1 2021.

Cliff Asness reported no remaining KALA BIO position as of Q1 2021 after selling out during the quarter.
Cliff Asness sold 8 KALA BIO shares in Q1 2021, an estimated $138K.
Cliff Asness first reported a position in KALA BIO in Q2 2020 and held it in 3 quarters.
Cliff Asness's KALA BIO position peaked at $253K in Q3 2020.
106 funds tracked by Wall St. Rank held KALA BIO as of Q1 2021.

Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.